Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope.
Sign Up to like & getrecommendations! Published in 2020 at "Cancer letters"
DOI: 10.1016/j.canlet.2020.09.023
Abstract: Despite being the subject of extensive research and clinical trials, neuroblastoma remains a major therapeutic challenge in pediatric oncology. The p53 protein is a central safeguard that protects cells against genome instability and malignant transformation.… read more here.
Keywords: p53; p53 mdm2; mdm2 pathway; pathway neuroblastoma ... See more keywords